11 results
10-K
2020 FY
TSHA
Taysha Gene Therapies Inc
3 Mar 21
Annual report
9:00am
and distribution capabilities. For example, recruiting and training a sales force is expensive and time consuming and could delay any product launch
8-K
EX-99.1
TSHA
Taysha Gene Therapies Inc
17 Dec 20
Taysha Gene Therapies Announces New cGMP Gene Therapy Manufacturing Facility
4:16pm
expenditure milestones, as well as a training grant of over $360,000 over a two- to three-year period. The Company will also receive a local incentive
10-Q
2020 Q3
TSHA
Taysha Gene Therapies Inc
12 Nov 20
Quarterly report
4:27pm
our own sales, marketing and distribution capabilities. For example, recruiting and training a sales force is expensive and time consuming and could
424B4
b1ybz68 5mnhsov4yue
25 Sep 20
Prospectus supplement with pricing info
12:00am
S-1/A
npv165ixpnjk 1c7
8 Sep 20
IPO registration (amended)
4:43pm
S-1
mor0cekhk6ihp
2 Sep 20
IPO registration
5:02pm
DRS
a7ygb
3 Aug 20
Draft registration statement
12:00am
- Prev
- 1
- Next